ACM
ABEO icon

ACT Capital Management’s Abeona Therapeutics ABEO Stock Holding History

ACT Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,120
Closed -$311K – 93
2021
Q3 		$311K Buy
+11,120
New +$356K 0.16% 71

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACT Capital Management's ABEO Position: Q4 2021 in Review

ACT Capital Management sold out of Abeona Therapeutics (ABEO) in Q4 2021, closing a stake of 11,120 shares — an estimated $311K sold.

ACT Capital Management first reported a position in ABEO in Q3 2021 and held it in 1 quarter. The position peaked at $311K in Q3 2021. 52 funds tracked by Wall St. Rank hold ABEO as of Q4 2021.

  • ACT Capital Management reported no remaining Abeona Therapeutics position as of Q4 2021 after selling out during the quarter.
  • ACT Capital Management sold 11,120 Abeona Therapeutics shares in Q4 2021, an estimated $311K.
  • ACT Capital Management first reported a position in Abeona Therapeutics in Q3 2021 and held it in 1 quarter.
  • ACT Capital Management's Abeona Therapeutics position peaked at $311K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2021.

Based on ACT Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.